The bispecific antibody therapeutics market – Roots Analysis

 A detailed assessment of the current market landscape of drug developers engaged in the development of bispecific antibody therapeutics.
 A comprehensive analysis of novel technology platforms that are either currently available or being developed for the generation of bispecific antibody therapeutics.
 Detailed profiles of marketed and clinical stage (phase II and phase III) bispecific antibody therapeutics.

Leave a Reply